Literature DB >> 30538891

Selective and super-selective C-arm based cone beam CT angiography (CBCTA) with DynaCT for CyberKnife radiosurgery planning of intracranial arteriovenous malformations (AVMs).

Oliver Edwin Holmes1,2,3, Janos Szanto4, Vered Tsehmaister Abitbul5, Taleb Al Mansoori6, Hanan Al-Qahtani5, John Sinclair7, Daniela Iancu5, Shawn Malone3.   

Abstract

BACKGROUND: Successful radiosurgery for intracranial arteriovenous malformations (AVMs) requires accurate delineation of the nidus in 3D. Exact targeting and precise equipment is needed to achieve obliteration of the nidus while minimizing toxicity to the surrounding brain. In some micro-AVMs and poorly visible AVMs we have used cone beam CT angiography (CBCTA) with selective and super-selective angiography where a micro-catheter is advanced into the feeding arteries- to assist with nidus definition for CyberKnife radiosurgery planning.
METHODS: Four patients who had AVMs inadequately visualized with MRI, MRA, CT, CTA, and dynamic CT angiography (dCTA) were identified for selective angiography (2 had super-selective angiography) for CyberKnife radiosurgery. The mean age at the time of treatment was 45 years (range: 22 - 71 years). All patients had suffered prior hemorrhage and were deemed inoperable. Super-selective angiography was done under general anesthesia to minimize motion artefact and the risk of arterial dissection. Angiography was performed using the biplane angiographic suite (ArtisQ; Siemens). Cone beam reconstructions were performed using DynaCT software. For each scan, volumetric data was acquired over 20 seconds in a single rotation of the C-arm mounted flat-panel detector cone-beam CT system. The data set was imported into the CyberKnife TPS and co-registered with the treatment planning CT, T2 MRI and Toshiba dCTA. Delineation of the AVM nidus was performed by the multi-disciplinary AVM team.
RESULTS: There were no adverse events related to the angiography or radiosurgery treatment. CBCTA data sets created using DynaCT were accurately co-registered with the treatment planning scans in the CyberKnife treatment planning system (Multiplan). For all 4 patients, feeding arteries, draining veins and nidi were clearly visualized and used to develop radiosurgery plans. Mean nidus size was 0.45cc (range: 0.07 - 1.00cc).
CONCLUSIONS: For intracranial micro-AVMs and AVMs otherwise poorly visualized using DSA, MRA, CTA or dCTA, selective and super-selective CBCTA images (created using DynaCT) can be successfully imported into the CyberKnife TPS to assist in nidus delineation. Advancement of a micro-catheter into the feeding arteries to allow continuous contrast injection during volumetric scanning constitutes super-selective CBCTA. This technique provides superior visualization of micro-AVMs and should be utilized for radiosurgery planning of poorly visualized AVMs.

Entities:  

Keywords:  C-arm based cone beam CT angiography (CBCT-A); CyberKnife radiosurgery; arteriovenous malformations; intracranial arteriovenous malformation; radiosurgery; selective angiography

Year:  2018        PMID: 30538891      PMCID: PMC6255721     

Source DB:  PubMed          Journal:  J Radiosurg SBRT


  19 in total

1.  Assessment of distortion in a three-dimensional rotational angiography system.

Authors:  R R Bridcut; R J Winder; A Workman; P Flynn
Journal:  Br J Radiol       Date:  2002-03       Impact factor: 3.039

2.  Use of Dyna-CT Angiography in Neuroendovascular Decision-Making. A Case Report.

Authors:  K Namba; Y Niimi; J K Song; A Berenstein
Journal:  Interv Neuroradiol       Date:  2009-04-15       Impact factor: 1.610

Review 3.  Treatment of brain arteriovenous malformations: a systematic review and meta-analysis.

Authors:  Janneke van Beijnum; H Bart van der Worp; Dennis R Buis; Rustam Al-Shahi Salman; L Jaap Kappelle; Gabriël J E Rinkel; Jan Willem Berkelbach van der Sprenkel; W Peter Vandertop; Ale Algra; Catharina J M Klijn
Journal:  JAMA       Date:  2011-11-09       Impact factor: 56.272

4.  Analysis of treatment failure after radiosurgery for arteriovenous malformations.

Authors:  T L Ellis; W A Friedman; F J Bova; P S Kubilis; J M Buatti
Journal:  J Neurosurg       Date:  1998-07       Impact factor: 5.115

5.  Preoperative or preembolization lesion targeting using rotational angiographic fiducial marking in the neuroendovascular suite.

Authors:  Siok Ping Lim; Howard Lesiuk; John Sinclair; Cheemun Lum
Journal:  J Neurosurg       Date:  2010-02-19       Impact factor: 5.115

6.  Repeat stereotactic radiosurgery of arteriovenous malformations: factors associated with incomplete obliteration.

Authors:  B E Pollock; D Kondziolka; L D Lunsford; D Bissonette; J C Flickinger
Journal:  Neurosurgery       Date:  1996-02       Impact factor: 4.654

7.  Radiation-related adverse effects observed on neuro-imaging several years after radiosurgery for cerebral arteriovenous malformations.

Authors:  M Yamamoto; M Hara; M Ide; Y Ono; M Jimbo; I Saito
Journal:  Surg Neurol       Date:  1998-04

Review 8.  Arteriovenous malformations.

Authors:  Ian G Fleetwood; Gary K Steinberg
Journal:  Lancet       Date:  2002-03-09       Impact factor: 79.321

9.  Surgical treatment of poorly visualised and complex cerebrovascular lesions using pre-operative angiographic data as angiographic DynaCT datasets for frameless stereotactic navigation.

Authors:  Jin Wee Tee; Michael Dally; Anoop Madan; Peter Hwang
Journal:  Acta Neurochir (Wien)       Date:  2012-05-05       Impact factor: 2.216

10.  Factors associated with successful arteriovenous malformation radiosurgery.

Authors:  B E Pollock; J C Flickinger; L D Lunsford; A Maitz; D Kondziolka
Journal:  Neurosurgery       Date:  1998-06       Impact factor: 4.654

View more
  1 in total

1.  Frameless Co-Registration of Biplane 2D Digital Subtraction Angiography Whole Frames and 3D Rotational Angiography-Based Cone-Beam Computed Tomography Angiogram on Dedicated Software for Stereotactic Radiosurgery of Cranial Vascular Malformations.

Authors:  Kazuhiro Ohtakara; Takashi Izumi; Kuniaki Tanahashi; Takeshi Kamomae; Kojiro Suzuki
Journal:  Cureus       Date:  2022-08-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.